Nathan T. Zwagerman

Nathan T. Zwagerman

Auto-generated profile, based on publicly available information

Nathan T. Zwagerman

Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2016 in Journal of Neurological Surgery Part B: Skull Base
Verified
Journal Article
Open access
PDF file
Nicholas RowanNicholas Rowan
Nicholas Rowan
NZNathan T. Zwagerman
Nathan T. Zwagerman
MHMolly E. Heft-Neal
Molly E. Heft-Neal
PGPaul A. Gardner
Paul A. Gardner
CSCarl H. Snyderman
Carl H. Snyderman
Objectives To compare the clinical utility of four juvenile nasal angiofibroma (JNA) staging systems in a large cohort of patients. Design Retrospective case series. Setting Tertiary referral academic center. Participants Pediatric patients undergoing surgical resection of JNAs between January 2008 and June 2015. Main Outcome Measures Intraoperative blood loss and transfusions, number of staged operations, postoperative residual disease, and recurrent disease. Results In total, 34 patients were identified; all underwent preoperative embolization followed by surgery. Of the 34 patients, 33 (97%) underwent an exclusively endoscopic surgical approach, with 6 (18%) requiring planned staged operations. Ten (29%) patients had residual disease and three (9%) required further surgical resection. Using the area under the curve (AUC) of receiver operating characteristic curves, the University of Pittsburgh Medical Center (UPMC) staging system was most predictive of patients who required staged procedures, received intraoperative transfusions, and had residual postoperative disease (AUC: 0.89, 0.88, 0.86, respectively). Conclusions The UPMC JNA staging system accounts for both route of skull base extension and tumor vascularity, which are two important tumor attributes in the age of preoperative embolization and endoscopic endonasal surgery. The UPMC staging system is a reliable modern staging system that closely reflects prognostic information and aids in surgical planning.

1 October 2016 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
SGStephanie Greene
Stephanie Greene
PLPhilip S. Lee
Philip S. Lee
CDChristopher P. Deibert
Christopher P. Deibert
ZTZachary J. Tempel
Zachary J. Tempel
NZNathan T. Zwagerman
Nathan T. Zwagerman
SEStephen P. Emery
Stephen P. Emery

21 August 2021 in Endocrinology
Verified
Journal Article
Open access
PDF file
LMLogan J Massman
Logan J Massman
MPMichaela Pereckas
Michaela Pereckas
NZNathan T Zwagerman
Nathan T Zwagerman
SSStephanie Olivier-Van Stichelen
Stephanie Olivier-Van Stichelen
Pituitary adenomas have a staggering 16.7% lifetime prevalence and can be devastating in many patients because of profound endocrine and neurologic dysfunction. To date, no clear genomic or epigenomic markers correlate with their onset or severity. Herein, we investigate the impact of the O-GlcNAc posttranslational modification in their etiology. Found in more than 7000 human proteins to date, O-GlcNAcylation dynamically regulates proteins in critical signaling pathways, and its deregulation is involved in cancer progression and endocrine diseases such as diabetes. In this study, we demonstrated that O-GlcNAc enzymes were upregulated, particularly in aggressive adrenocorticotropin (ACTH)-secreting tumors, suggesting a role for O-GlcNAcylation in pituitary adenoma etiology. In addition to the demonstration that O-GlcNAcylation was essential for their proliferation, we showed that the endocrine function of pituitary adenoma is also dependent on O-GlcNAcylation. In corticotropic tumors, hypersecretion of the proopiomelanocortin (POMC)-derived hormone ACTH leads to Cushing disease, materialized by severe endocrine disruption and increased mortality. We demonstrated that Pomc messenger RNA is stabilized in an O-GlcNAc-dependent manner in response to corticotrophin-releasing hormone (CRH). By affecting Pomc mRNA splicing and stability, O-GlcNAcylation contributes to this new mechanism of fast hormonal response in corticotropes. Thus, this study stresses the essential role of O-GlcNAcylation in ACTH-secreting adenomas’ pathophysiology, including cellular proliferation and hypersecretion.

1 May 2019 in World Neurosurgery
Verified
Journal Article
Closed access
RGRamesh Grandhi
Ramesh Grandhi
LBLeonardo B.C. Brasiliense
Leonardo B.C. Brasiliense
RWRichard Williamson
Richard Williamson
NZNathan T. Zwagerman
Nathan T. Zwagerman
ESEric Sauvageau
Eric Sauvageau
RHRicardo A. Hanel
Ricardo A. Hanel

1 February 2016 in Journal of Neurological Surgery Part B: Skull Base
Verified
Journal Article
Closed access
NKNicolas K Khattar
Nicolas K Khattar
JCJoseph D. Chabot
Joseph D. Chabot
GZGeorgios A. Zenonos
Georgios A. Zenonos
NZNathan T. Zwagerman
Nathan T. Zwagerman
EGEzequiel D. Goldschmidt
Ezequiel D. Goldschmidt
PGPaul A. Gardner
Paul A. Gardner
Introduction: The onset of seizures following craniotomy has been estimated at 15–20%. This has prompted the routine use of anti-epileptic drug (AED) prophylaxis among many surgeons. Endoscopic endonasal approaches (EEA) have increased in popularity for treatment of a variety of intracranial pathologies. One of the benefits of the expanded endonasal approach is that it allows access to the skull base with minimal cortical manipulation, theoretically reducing the incidence of post-operative seizures. However, the incidence of post-operative seizures in this population is unknown. Methods: This is a retrospective chart review of all adult patients undergoing EEA that developed post-operative seizures from July, 2007 through June, 2014. A list of patients was generated by an electronic search using the billing codes for EEG and endoscopy. Patients were excluded if they had a history of seizures or presented with a seizure pre-operatively, history of craniotomy, combined EEA and craniotomy, or if the EEG and clinical impression was not consistent with a seizure. Patients were included if they had EEG findings consistent with seizure, or a witnessed clinical event consistent with seizure activity. The same search method was used to determine the number of patients who had new onset seizures following craniotomies for tumor resection. Results: 9 patients met inclusions criteria for seizures following EEA, 2 meningiomas, 1 esthesioneuroblastoma, 1 pituitary adenoma, 1 chondrosarcoma, 1 squamous cell carcinoma, 1 spontaneous CSF leak, 1 epidermoid, and one Rathke’s cleft cyst (RCC). Clinical and radiographic characteristics were quite diverse in these patients. Although 4 patients had seizures within one week of their surgery, the mean number of days in the remaining patients was 241 (range 61–540, median 185). The average size of the tumor was 2.95 cm (range 1.3–5.2, median 3.75). Seven patients had intra-operative CSF leaks. Except for two patients with meningiomas and one patient with RCC, all patients had at least one complication including hematoma (1), meningitis (3), post-op CSF leak (2), marked pneumocephalus (1), or abscess (1). All patients were managed with anti-epileptic drugs, and there were no deaths during the study period. During the study period, 9 (0.84%) out of 1518 patients experienced in the EEA group and 28 (1.6%) out of 1704 patients in the open craniotomy for tumor group experienced seizures post-operatively (p = 0.00614). 827 procedures from the EEA group were intracranial, excluding patients without intra-operative CSF leaks. In the open craniotomy group, 792 of these patients had extra-axial tumors. In this cohort, 24 (3.0%) had post-operative seizures, 15 (1.8%) of which were meningiomas. Conclusion: Seizures are a rare occurrence following uncomplicated EEA. This rate is significantly lower than the risk associated with craniotomy for the same diagnosis, despite the fact that patients undergoing craniotomies are routinely administered AED’s. Further studies must be done to elucidate the risk factors associated with post-operative seizures in both populations.

13 August 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
LMLogan J Massman
Logan J Massman
MPMichaela Pereckas
Michaela Pereckas
NZNathan T Zwagerman
Nathan T Zwagerman
SSStephanie Olivier-Van Stichelen
Stephanie Olivier-Van Stichelen
Pituitary adenomas have a staggering 16.7% lifetime prevalence and can be devastating in many patients due to profound endocrine and neurologic dysfunction. To date, no clear genomic or epigenomic markers correlates with their onset or severity. Herein, we investigate the impact of the O -GlcNAc post-translational modification in their etiology. Found in over 5000 human proteins to date, O -GlcNAcylation dynamically regulates proteins in critical signaling pathways, and its deregulation is involved in cancers progression and endocrine diseases such as diabetes. In this study, we demonstrate that O -GlcNAcylation enzymes were upregulated, particularly in aggressive ACTH-secreting tumors, suggesting a role for O -GlcNAcylation in pituitary adenoma etiology. In addition to the demonstration that O -GlcNAcylation was essential for their proliferation, we show that the endocrine function of pituitary adenoma is also dependent on O -GlcNAcylation. In corticotropic tumors, hyper-secretion of the proopiomelanocortin (POMC)-derived hormone ACTH leads to Cushing’s disease, materialized by severe endocrine disruption and increased mortality. We demonstrate that Pomc mRNA is stabilized in an O -GlcNAc-dependent manner in response to corticotropic-stimulating hormone (CRH). By impacting Pomc mRNA splicing and stability, O -GlcNAcylation contributes to this new mechanism of fast hormonal response in corticotropes. Thus, this study stresses the essential role of O -GlcNAcylation in ACTH-secreting adenomas’ pathophysiology, including cellular proliferation and hypersecretion.